3 completed. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 3 |
Follow Clinically Isolated Syndrome: new trials by email Literature Review of Clinically Isolated Syndrome trials Research Report on Clinically Isolated Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study Evaluating B Cell Levels In Infants Potentially Exposed To Ocrelizumab During Pregnancy Ocrelizumab - Multiple Sclerosis, Clinically Isolated Syndrome | Phase 4 | Completed | Hoffmann-La Roche | 70 | 2022-04-13 | 2026-04-15 |
| A Study Evaluating B Cell Levels In Infants Of Lactating Women With CIS Or MS Receiving Ocrelizumab Ocrelizumab - Multiple Sclerosis, Clinically Isolated Syndrome | Phase 4 | Completed | Hoffmann-La Roche | 26 | 2021-09-16 | 2026-01-14 |
| Effectiveness of Rebif® in Clinically Isolated Syndrome and Relapsing Multiple Sclerosis Using RebiSmart™ Rebif - Relapsing Multiple Sclerosis, Clinically Isolated Syndrome | Phase 4 | Completed | Merck KGaA, Darmstadt, Germany | 106 | 2014-12-31 | 2018-03-30 |
Multiple Sclerosis (2) · Breast Feeding (1)
Autoimmune Diseases (2) · Autoimmune Diseases of the Nervous System (2) · Demyelinating Autoimmune Diseases, CNS (2) · Demyelinating Diseases (2) · Immune System Diseases (2) · Nervous System Diseases (2) · Behavior (1) · Feeding Behavior (1)
ocrelizumab (2) · Interferon beta-1a (1)
Hoffmann-La Roche (2) · Merck KGaA, Darmstadt, Germany (1)
Germany (2) · Spain (2) · United States (2) · France (1) · Switzerland (1) · United Kingdom (1)
2014 (1)